| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |















From the Department of Neurology,* Department of Human Pathology,¶ Gunma University Graduate School of Medicine, Gunma, Japan; the Department of Neurology,
Neuroscience, Biophysiological Science, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan; the Centre for Research in Neurodegenerative Diseases,
Departments of Medicine (Neurology) and Laboratory Medicine and Pathobiology, University of Toronto, University Health Network, Toronto, Ontario, Canada; the Department of Neurology,¶¶ Maebashi Red Cross Hospital, Gunma, Japan; the Mitsubishi Kagaku Institute of Life Sciences,
Tokyo, Japan; the Department of Molecular Neurobiology,
Tokyo Institute of Psychiatry, Tokyo, Japan; R&D Division,|| Tsumura & Co., Ltd., Ibaraki, Japan; the Laboratory of Development,** Wakanyaku Medical Institute. Ltd., Gunma, Japan; and the Mayo Clinic Jacksonville,
Jacksonville, Florida
Correspondence: Address correspondence to Masaki Ikeda, M.D., Ph.D., Department of Neurology, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma, 371-8511, Japan, E-mail: mikeda{at}med.gunma-u.ac.jp
Missense mutations of the tau gene cause autosomal dominant frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17), an illness characterized by progressive personality changes, dementia, and parkinsonism. There is prominent frontotemporal lobe atrophy of the brain accompanied by abundant tau accumulation with neurofibrillary tangles and neuronal cell loss. Using a hamster prion protein gene expression vector, we generated several independent lines of transgenic (Tg) mice expressing the longest form of the human four-repeat tau with the R406W mutation associated with FTDP-17. The TgTauR406W 21807 line showed tau accumulation beginning in the hippocampus and amygdala at 6 months of age, which subsequently spread to the cortices and subcortical areas. The accumulated tau was phosphorylated, ubiquitinated, conformationally changed, argyrophilic, and sarcosyl-insoluble. Activation of GSK-3ß and astrocytic induction of mouse tau were observed. Astrogliosis and microgliosis correlated with prominent tau accumulation. Electron microscopic examination revealed the presence of straight filaments. Behavioral tests showed motor disturbances and progressive acquired memory loss between 10 to 12 months of age. These findings suggested that TgTauR406W mice would be a useful model in the study of frontotemporal dementia and other tauopathies such as Alzheimers disease (AD).
This article has been cited by other articles:
![]() |
C. Tackenberg and R. Brandt Divergent Pathways Mediate Spine Alterations and Cell Death Induced by Amyloid-{beta}, Wild-Type Tau, and R406W Tau J. Neurosci., November 18, 2009; 29(46): 14439 - 14450. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Leroy, A. Bretteville, K. Schindowski, E. Gilissen, M. Authelet, R. De Decker, Z. Yilmaz, L. Buee, and J.-P. Brion Early Axonopathy Preceding Neurofibrillary Tangles in Mutant Tau Transgenic Mice Am. J. Pathol., September 1, 2007; 171(3): 976 - 992. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Murakami, E. Paitel, T. Kawarabayashi, M. Ikeda, M. A. Chishti, C. Janus, E. Matsubara, A. Sasaki, T. Kawarai, A. L. Phinney, et al. Cortical Neuronal and Glial Pathology in TgTauP301L Transgenic Mice: Neuronal Degeneration, Memory Disturbance, and Phenotypic Variation Am. J. Pathol., October 1, 2006; 169(4): 1365 - 1375. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Schindowski, A. Bretteville, K. Leroy, S. Begard, J.-P. Brion, M. Hamdane, and L. Buee Alzheimer's Disease-Like Tau Neuropathology Leads to Memory Deficits and Loss of Functional Synapses in a Novel Mutated Tau Transgenic Mouse without Any Motor Deficits Am. J. Pathol., August 1, 2006; 169(2): 599 - 616. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Boekhoorn, D. Terwel, B. Biemans, P. Borghgraef, O. Wiegert, G. J. A. Ramakers, K. de Vos, H. Krugers, T. Tomiyama, H. Mori, et al. Improved long-term potentiation and memory in young tau-P301L transgenic mice before onset of hyperphosphorylation and tauopathy. J. Neurosci., March 29, 2006; 26(13): 3514 - 3523. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Delobel, I. Lavenir, B. Ghetti, M. Holzer, and M. Goedert Cell-Cycle Markers in a Transgenic Mouse Model of Human Tauopathy: Increased Levels of Cyclin-Dependent Kinase Inhibitors p21Cip1 and p27Kip1 Am. J. Pathol., March 1, 2006; 168(3): 878 - 887. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ramsden, L. Kotilinek, C. Forster, J. Paulson, E. McGowan, K. SantaCruz, A. Guimaraes, M. Yue, J. Lewis, G. Carlson, et al. Age-Dependent Neurofibrillary Tangle Formation, Neuron Loss, and Memory Impairment in a Mouse Model of Human Tauopathy (P301L) J. Neurosci., November 16, 2005; 25(46): 10637 - 10647. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |